VISIUS Surgical Theatre with intraoperative
MRI included in first of its kind Northern Europe installation
MINNEAPOLIS, MN, Jan. 20, 2015 /PRNewswire/ - IMRIS Inc. (NASDAQ:
IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that a
VISIUS Surgical Theatre with intraoperative MRI (iMRI) will be
integrated among four hybrid operating suites Siemens Healthcare
recently sold to Sahlgrenska University Hospital in an example of
growing cooperation between IMRIS and Siemens Healthcare.
"This represents the close and progressing global collaboration
IMRIS has with Siemens Healthcare to bring advanced imaging to the
operating environment," said IMRIS President and CEO Jay D. Miller. "Already many of the top
neuroscience centers around the world are making intraoperative MR
their standard of care."
Sahlgrenska University Hospitals, one of the largest hospital
systems in northern Europe, is
associated with the Sahlgrenska Academy at the University of
Gothenburg in Gothenburg, Sweden. This sale involves both
radiology and MRI systems in four hybrid operating rooms for the
hospital's new imaging center with clinical opening planned in
2016.
"The benefit for the patient is obvious with minimally invasive
surgery since he or she can leave the hospital much sooner," said
Johan Mälsjö, Head of Division of Imaging and Therapy at Siemens
Healthcare in Sweden, regarding
the sale. "This is also beneficial for the hospital which needs to
manage its resources carefully. Siemens Healthcare sees a strong
trend in this and expects an increasing demand for similar
solutions."
The VISIUS iMRI will feature a two-room suite where a diagnostic
quality MR travels to the patient using ceiling-mounted rails. The
fully integrated suite allows the scanner to move between an
operating room (OR) and a diagnostic room, providing neurosurgeons
on-demand access to high resolution images – before, during and
after procedures – without moving the patient from the OR table.
Published studies have demonstrated that access to advanced imaging
technology during procedures leads to improved precision and
patient outcomes and reduced returns to surgery, particularly for
neurosurgical conditions.
About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a
global leader in providing image guided therapy solutions through
its VISIUS Surgical Theatre – a revolutionary, multifunctional
surgical environment that provides unmatched intraoperative vision
to clinicians to assist in decision making and enhance precision in
treatment. The multi-room suites incorporate diagnostic quality
high-field MR, CT and angio modalities accessed effortlessly in the
operating room setting. VISIUS Surgical Theatres serve the
neurosurgical, spinal, cardiovascular and cerebrovascular markets
and have been selected by 61 leading medical institutions around
the world. Learn more by visiting
www.imris.com.
SOURCE IMRIS Inc.
